| FCBSX | MVCAX | FCBSX / MVCAX | |
| Total Expense Ratio | 1.66 | 0.97 | 171% |
| Annual Report Gross Expense Ratio | 1.68 | 0.98 | 171% |
| Fund Existence | 25 years | 25 years | - |
| Gain YTD | 11.121 | 17.692 | 63% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 1000 | 1000 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 783M | 17.7B | 4% |
| Annual Yield % from dividends | 0.20 | 1.09 | 18% |
| Returns for 1 year | 6.66 | 13.14 | 51% |
| Returns for 3 years | 23.07 | 29.68 | 78% |
| Returns for 5 years | 1.30 | 20.74 | 6% |
| Returns for 10 years | 10.25 | 86.14 | 12% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MIINX | 20.96 | 0.20 | +0.96% |
| BNY Mellon International Inv | |||
| BERCX | 18.97 | 0.12 | +0.64% |
| Carillon Chartwell Mid Cap Value I | |||
| AEYGX | 40.38 | 0.22 | +0.55% |
| American Century Disciplined Core Eq R5 | |||
| GSBGX | 25.61 | 0.14 | +0.55% |
| GMO Small Cap Quality Fund Class VI | |||
| JGAVX | 104.59 | 0.48 | +0.46% |
| JPMorgan US Value R3 | |||